Clinical Annotation ID	Variant/Haplotypes	Gene	Level of Evidence	Level Override	Level Modifiers	Score	Phenotype Category	PMID Count	Evidence Count	Drug(s)	Phenotype(s)	Latest History Date (YYYY-MM-DD)	URL	Specialty Population
1445117525	rs193922876	RYR1	1A		Tier 1 VIP	100.25	Toxicity	1	2	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445117525	Pediatric
1183705788	rs118192170	RYR1	1A		Tier 1 VIP	100.25	Toxicity	3	4	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705788	
1445400186	rs1801086	RYR1	1A		Rare Variant; Tier 1 VIP	101.25	Toxicity	11	12	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400186	Pediatric
1139506787	CYP2A6*1, CYP2A6*1x2, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*12, CYP2A6*13, CYP2A6*14, CYP2A6*15, CYP2A6*17, CYP2A6*19, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*38, CYP2A6*46	CYP2A6	1B		Tier 1 VIP	36.0	Metabolism/PK	27	40	nicotine	Tobacco Use Disorder	2022-09-29	https://www.pharmgkb.org/clinicalAnnotation/1139506787	
1451434920	rs267606617	MT-RNR1	1A		Rare Variant; Tier 1 VIP	101.25	Toxicity	5	6	amikacin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451434920	Pediatric
1445400222	rs193922772	RYR1	1A		Rare Variant; Tier 1 VIP	102.5	Toxicity	11	12	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400222	Pediatric
1183689931	CYP3A4*1, CYP3A4*18, CYP3A4*20, CYP3A4*22, CYP3A4*36	CYP3A4	1B		Tier 1 VIP	34.25	Metabolism/PK	37	43	tacrolimus	heart transplantation;Kidney Transplantation;laparoscopic sleeve gastrectomy;liver transplantation;lung transplantation	2022-03-23	https://www.pharmgkb.org/clinicalAnnotation/1183689931	Pediatric
1445400247	rs193922816	RYR1	1A		Rare Variant; Tier 1 VIP	103.0	Toxicity	9	10	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400247	Pediatric
1183701210	HLA-A*33:03	HLA-A	2B			12.75	Toxicity	6	7	allopurinol	Drug Hypersensitivity;Stevens-Johnson Syndrome	2022-10-19	https://www.pharmgkb.org/clinicalAnnotation/1183701210	
1445400887	rs112563513	RYR1	1A		Rare Variant; Tier 1 VIP	102.25	Toxicity	7	9	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400887	Pediatric
1183705797	rs118192175	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	3	5	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705797	
1445400894	rs28933396	RYR1	1A		Rare Variant; Tier 1 VIP	102.25	Toxicity	16	17	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400894	
655385400	rs2108622	CYP4F2	1A		Tier 1 VIP	170.0	Dosage	69	72	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385400	Pediatric
1445400910	rs193922747	RYR1	1A		Rare Variant; Tier 1 VIP	100.75	Toxicity	6	7	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400910	
1183960790	rs193922525	CFTR	1A		Rare Variant; Tier 1 VIP	202.0	Efficacy	2	4	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960790	Pediatric
981202609	rs4673993	ATIC	2B			11.875	Efficacy	5	5	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202609	
1449157773	rs118192168	RYR1	1A		Rare Variant; Tier 1 VIP	101.25	Toxicity	12	13	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449157773	Pediatric
1183705802	rs118192176	RYR1	1A		Rare Variant; Tier 1 VIP	103.75	Toxicity	21	23	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705802	Pediatric
981239773	rs8099917	IFNL3	1B	Yes: Assigned level 1B because variant is not part of the CPIC guideline recommendation, this variant is in high LD with CPIC variant rs12979860.		93.75	Efficacy	45	59	interferons;peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-29	https://www.pharmgkb.org/clinicalAnnotation/981239773	Pediatric
981419263	HLA-B*15:02:01, HLA-B*15:11:01	HLA-B	1A		Tier 1 VIP	413.5	Toxicity	49	59	carbamazepine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-03-03	https://www.pharmgkb.org/clinicalAnnotation/981419263	Pediatric
981202714	rs4961	ADD1	2B			12.0	Efficacy	8	8	hydrochlorothiazide	Essential hypertension;Hypertension	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202714	
981204044	rs9923231	VKORC1	1A		Tier 1 VIP	147.75	Dosage	20	25	acenocoumarol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204044	
1447673669	rs193922809	RYR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673669	
1447673759	rs118192178	RYR1	1A		Rare Variant; Tier 1 VIP	101.75	Toxicity	5	8	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673759	Pediatric
1447673778	rs193922818	RYR1	1A		Rare Variant; Tier 1 VIP	101.0	Toxicity	7	9	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673778	Pediatric
981475450	rs121434569	EGFR	2B		Rare Variant	9.0	Efficacy	11	11	erlotinib	Adenocarcinoma;Carcinoma, Non-Small-Cell Lung;Drug Resistance;Lung Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981475450	
1183705807	rs118192177	RYR1	1A		Rare Variant; Tier 1 VIP	103.25	Toxicity	22	25	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705807	Pediatric
1451243980	CYP2B6*1, CYP2B6*2, CYP2B6*6, CYP2B6*18, CYP2B6*38	CYP2B6	1A		Tier 1 VIP	211.5	Toxicity	12	14	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451243980	
1183705817	rs28933397	RYR1	1A		Rare Variant; Tier 1 VIP	102.75	Toxicity	10	11	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705817	Pediatric
1183705822	rs121918595	RYR1	1A		Rare Variant; Tier 1 VIP	100.75	Toxicity	6	7	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705822	Pediatric
1183705827	rs121918594	RYR1	1A		Rare Variant; Tier 1 VIP	101.25	Toxicity	7	9	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705827	
1445400232	rs193922802	RYR1	1A		Rare Variant; Tier 1 VIP	101.0	Toxicity	9	11	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400232	Pediatric
1183888969	rs12979860	IFNL3;IFNL4	1A			219.0	Efficacy	9	11	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin;telaprevir	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183888969	
1183960318	rs121908755	CFTR	1A		Rare Variant; Tier 1 VIP	202.5	Efficacy	5	7	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960318	Pediatric
1183617854	CYP2C19*1, CYP2C19*2	CYP2C19	1A		Tier 1 VIP	102.0	Metabolism/PK	1	2	doxepin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617854	
1183624491	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	209.3125	Metabolism/PK	7	11	pantoprazole		2021-04-26	https://www.pharmgkb.org/clinicalAnnotation/1183624491	Pediatric
1451357200	rs4149056	SLCO1B1	1A		Tier 1 VIP	105.5	Toxicity	8	9	rosuvastatin	statin-related myopathy	2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451357200	
1449156175	HLA-C*04:01:01:01	HLA-C	2B			17.0	Toxicity	8	9	nevirapine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Exanthema;Hypersensitivity;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449156175	
613978931	rs3812718	SCN1A	2B			15.25	Dosage	6	7	carbamazepine	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/613978931	
1451237200	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*9	TPMT	1A		Tier 1 VIP	221.25	Dosage	20	27	mercaptopurine	dose reduction	2021-06-08	https://www.pharmgkb.org/clinicalAnnotation/1451237200	Pediatric
1184661194	rs2108622	CYP4F2	2A		Tier 1 VIP	11.75	Dosage	14	15	acenocoumarol	Atrial Fibrillation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184661194	
1451275020	rs3918290	DPYD	1A		Rare Variant; Tier 1 VIP	207.0	Other	23	27	fluorouracil		2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451275020	Pediatric
655385392	rs9934438	VKORC1	1B	Yes: Assigned level 1B because variant is not specifically mentioned in clinical guidelines or labels, in high LD with rs9923231	Tier 1 VIP	109.625	Dosage	49	52	warfarin		2021-11-19	https://www.pharmgkb.org/clinicalAnnotation/655385392	Pediatric
1451141900	CYP2D6*5, CYP2D6*17	CYP2D6	1A		Tier 1 VIP	101.75	Efficacy	2	3	hydrocodone	Pain	2022-01-11	https://www.pharmgkb.org/clinicalAnnotation/1451141900	
1451286320	rs1801159	DPYD	1A		Tier 1 VIP	81.25	Toxicity	12	13	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451286320	
1451282240	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6	CYP2D6	1A		Tier 1 VIP	201.75	Toxicity	2	4	atomoxetine	Attention Deficit Disorder with Hyperactivity	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1451282240	
1451274045	rs67376798	DPYD	1A		Rare Variant; Tier 1 VIP	202.0	Other	11	14	fluorouracil		2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451274045	Pediatric
1451287360	rs2297595	DPYD	1A		Tier 1 VIP	84.0	Toxicity	17	19	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451287360	
1451286326	rs1801158	DPYD	1A		Tier 1 VIP	82.5	Toxicity	13	14	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451286326	
1451290840	rs116855232	NUDT15	1A		Tier 1 VIP	130.375	Dosage	16	19	mercaptopurine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451290840	Pediatric
1451287240	rs1801265	DPYD	1A		Tier 1 VIP	93.25	Toxicity	11	13	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451287240	
1451265780	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	1A		Tier 1 VIP	209.375	Toxicity	5	8	clomipramine	Depressive Disorder, Major	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451265780	
1451274984	rs3918290	DPYD	1A		Rare Variant; Tier 1 VIP	222.25	Toxicity	28	31	capecitabine	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451274984	
1451666660	rs2231142	ABCG2	1A		Tier 1 VIP	115.625	Metabolism/PK	11	12	rosuvastatin		2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/1451666660	
1451436133	rs267606618	MT-RNR1	1A		Rare Variant; Tier 1 VIP	101.0	Toxicity	4	5	gentamicin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451436133	Pediatric
1451285240	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*10x2, CYP2D6*11, CYP2D6*17, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	226.5625	Efficacy	56	143	tamoxifen	Breast Neoplasms	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1451285240	
1451287440	rs17376848	DPYD	1A		Tier 1 VIP	96.25	Toxicity	9	10	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451287440	
1451263877	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	3	5	enflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451263877	
1451282340	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	384.625	Efficacy	100	159	clopidogrel	Cardiovascular Diseases	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451282340	
1451274140	rs115232898	DPYD	1A		Rare Variant; Tier 1 VIP	101.75	Other	4	5	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451274140	
1451666740	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	107.625	Metabolism/PK	5	11	fluvastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451666740	
1444699308	rs267606619	MT-RNR1	1A		Rare Variant; Tier 1 VIP	102.75	Toxicity	8	9	aminoglycoside antibacterials	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1444699308	Pediatric
1451285360	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	CYP2D6	1A		Tier 1 VIP	204.875	Toxicity	6	8	nortriptyline	Depressive Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451285360	
1451155020	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	227.1875	Metabolism/PK	29	43	tramadol		2021-10-28	https://www.pharmgkb.org/clinicalAnnotation/1451155020	Pediatric
1451282840	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	1A		Tier 1 VIP	200.375	Toxicity	7	10	citalopram	Depressive Disorder	2022-03-11	https://www.pharmgkb.org/clinicalAnnotation/1451282840	
1444699743	rs267606618	MT-RNR1	1A		Rare Variant; Tier 1 VIP	102.0	Toxicity	3	4	aminoglycoside antibacterials	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1444699743	
1451274165	rs75017182	DPYD	1A		Tier 1 VIP	200.0	Toxicity	6	8	capecitabine	Neoplasms	2022-10-27	https://www.pharmgkb.org/clinicalAnnotation/1451274165	
1451276160	rs55886062	DPYD	1A		Rare Variant; Tier 1 VIP	201.5	Toxicity	10	12	capecitabine	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451276160	
1451231100	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	200.125	Metabolism/PK	2	4	siponimod		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451231100	
1183616718	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*36, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	216.0625	Metabolism/PK	19	35	codeine		2021-11-01	https://www.pharmgkb.org/clinicalAnnotation/1183616718	Pediatric
1451264020	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	5	7	succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264020	Pediatric
1451282440	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	380.25	Efficacy;Toxicity	62	117	clopidogrel	Acute coronary syndrome;Cardiovascular Diseases;Ischemic Attack, Transient;Stroke	2022-01-19	https://www.pharmgkb.org/clinicalAnnotation/1451282440	
1451286040	rs1801160	DPYD	1A		Tier 1 VIP	101.75	Toxicity	13	14	capecitabine	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451286040	
1451265560	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*4, CYP2D6*5	CYP2D6	1A		Tier 1 VIP	208.125	Dosage	3	6	imipramine	Depressive Disorder	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451265560	
1451264060	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	enflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264060	
1451237940	rs9923231	VKORC1	1A		Tier 1 VIP	117.0	Dosage	10	11	phenprocoumon		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451237940	Pediatric
1451275220	rs55886062	DPYD	1A		Rare Variant; Tier 1 VIP	201.75	Other	9	11	fluorouracil		2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451275220	Pediatric
1445400206	rs118192122	RYR1	1A		Rare Variant; Tier 1 VIP	103.0	Toxicity	18	19	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400206	Pediatric
1445400156	rs193922803	RYR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	6	7	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400156	
1447676001	rs118192116	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	1	2	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447676001	
655385024	rs2359612	VKORC1	1B		Tier 1 VIP	38.25	Dosage	14	15	warfarin		2021-11-19	https://www.pharmgkb.org/clinicalAnnotation/655385024	
1451263966	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	4	6	methoxyflurane		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451263966	Pediatric
1451274200	rs78060119	DPYD	1A		Rare Variant; Tier 1 VIP	100.0	Other	2	3	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451274200	
655384733	rs7294	VKORC1	1B		Tier 1 VIP	43.25	Dosage	21	22	warfarin		2021-11-19	https://www.pharmgkb.org/clinicalAnnotation/655384733	
1451263986	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	5	7	isoflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451263986	Pediatric
1451263980	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	4	5	halothane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451263980	Pediatric
1451263973	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	4	6	sevoflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451263973	Pediatric
1184648909	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*4, TPMT*6, TPMT*9, TPMT*12	TPMT	1A		Tier 1 VIP	225.625	Toxicity	30	44	mercaptopurine		2022-04-13	https://www.pharmgkb.org/clinicalAnnotation/1184648909	Pediatric
1451286020	rs1801160	DPYD	1A		Tier 1 VIP	108.5	Toxicity	14	15	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451286020	Pediatric
1451214480	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	1A		Tier 1 VIP	421.75	Metabolism/PK	143	166	tacrolimus	heart transplantation;hematopoietic stem cell transplantation;Kidney Transplantation;lung transplantation	2022-03-11	https://www.pharmgkb.org/clinicalAnnotation/1451214480	Pediatric
1451332611	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	1A		Tier 1 VIP	102.0	Toxicity	3	4	desipramine	Depressive Disorder;Depressive Disorder, Major	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451332611	
1447673787	rs193922878	RYR1	1A		Tier 1 VIP	101.0	Toxicity	5	6	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673787	
1451288200	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	CYP2D6	1A		Tier 1 VIP	203.625	Toxicity	8	11	codeine	Pain	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451288200	Pediatric
1451288220	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*17, CYP2D6*40	CYP2D6	1A		Tier 1 VIP	210.25	Efficacy	7	12	codeine	Pain	2022-01-11	https://www.pharmgkb.org/clinicalAnnotation/1451288220	Pediatric
1451264140	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	sevoflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264140	
1446905703	rs7270101	ITPA	2B			8.0	Toxicity	6	6	peginterferon alfa-2b;ribavirin	Anemia;Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446905703	
1451259580	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	211.375	Toxicity	6	9	amitriptyline	Depressive Disorder	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451259580	
1451264081	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	halothane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264081	
1447675871	rs193922753	RYR1	1A		Rare Variant; Tier 1 VIP	100.75	Toxicity	3	4	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447675871	
1447676077	rs193922807	RYR1	1A		Tier 1 VIP	100.0	Toxicity	2	3	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447676077	Pediatric
1444842106	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29	CYP2C9	1A		Tier 1 VIP	104.125	Metabolism/PK	3	6	flurbiprofen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444842106	
981345350	rs4149056	SLCO1B1	1A		Tier 1 VIP	114.125	Metabolism/PK	13	16	rosuvastatin	Hypercholesterolemia	2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/981345350	Pediatric
1451678240	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	105.5	Toxicity	8	9	rosuvastatin	statin-related myopathy	2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/1451678240	
1448102439	rs11881222	IFNL3	2A			11.5	Efficacy	4	4	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C;HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448102439	
1451678600	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	102.0	Toxicity	2	4	fluvastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451678600	
1451677736	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	106.0	Toxicity	20	21	atorvastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451677736	
1451678620	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	101.625	Metabolism/PK	4	6	fluvastatin		2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451678620	
1447989784	rs56038477	DPYD	1A		Tier 1 VIP	208.5	Toxicity	8	10	fluorouracil	Neoplasms	2022-10-27	https://www.pharmgkb.org/clinicalAnnotation/1447989784	
1451264087	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	isoflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264087	
981345293	rs4149056	SLCO1B1	1A		Tier 1 VIP	113.0	Metabolism/PK	13	19	pravastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/981345293	Pediatric
1183700410	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14	CYP2D6	1A		Tier 1 VIP	103.4375	Metabolism/PK	10	13	fluvoxamine	Depressive Disorder	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183700410	
1451264128	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264128	
1451264120	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	methoxyflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451264120	
655384011	rs4149056	SLCO1B1	1A		Tier 1 VIP	211.75	Toxicity	9	12	simvastatin	statin-related myopathy	2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/655384011	
1451681540	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	110.625	Metabolism/PK	9	10	simvastatin;simvastatin acid		2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/1451681540	Pediatric
1449191373	rs397508256	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191373	
1183619154	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	2A		Tier 1 VIP	8.75	Metabolism/PK	5	10	mirtazapine		2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183619154	
1451677518	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	103.5	Toxicity	1	2	lovastatin	statin-related myopathy	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451677518	
1043880818	rs4149056	SLCO1B1	1A		Tier 1 VIP	207.25	Toxicity	17	19	atorvastatin	statin-related myopathy	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1043880818	
827923032	rs3745274	CYP2B6	1A		Tier 1 VIP	229.0625	Metabolism/PK	77	89	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827923032	Pediatric
827923042	rs3745274	CYP2B6	1A		Tier 1 VIP	109.25	Toxicity	29	31	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827923042	Pediatric
1451678626	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	101.25	Toxicity	2	3	fluvastatin	statin-related myopathy	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451678626	
981201535	rs2297595	DPYD	1A	Yes: Assigned level 1A because variant is included in CPIC guideline	Tier 1 VIP	75.5	Toxicity	17	19	fluorouracil	Neoplasms	2021-03-29	https://www.pharmgkb.org/clinicalAnnotation/981201535	
1183616940	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	1A		Tier 1 VIP	205.8125	Metabolism/PK	9	12	imipramine	Depressive Disorder, Major;Mental Disorders	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183616940	
981201946	rs1801158	DPYD	1A		Tier 1 VIP	87.75	Toxicity	13	14	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201946	
1183618725	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17	CYP2D6	1A		Tier 1 VIP	228.375	Metabolism/PK	16	34	nortriptyline	Depressive Disorder, Major	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183618725	
1447989732	rs72549306	DPYD	1A		Rare Variant; Tier 1 VIP	100.0	Other	2	4	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989732	
1447964187	rs78655421	CFTR	1A		Rare Variant; Tier 1 VIP	206.0	Efficacy	5	8	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447964187	
1183621726	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	1A		Tier 1 VIP	104.125	Metabolism/PK	4	5	flecainide	Arrhythmias, Cardiac	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1183621726	
1451435945	rs267606619	MT-RNR1	1A		Rare Variant; Tier 1 VIP	101.25	Toxicity	8	9	gentamicin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451435945	Pediatric
1451954560	rs7557402	EPAS1	2B		Rare Variant	3.0	Toxicity	1	1	sorafenib	Drug Toxicity	2022-12-02	https://www.pharmgkb.org/clinicalAnnotation/1451954560	
981201981	rs1801265	DPYD	1A		Tier 1 VIP	93.25	Toxicity	17	19	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201981	Pediatric
981203618	rs67376798	DPYD	1A		Rare Variant; Tier 1 VIP	233.75	Toxicity	23	25	fluorouracil	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/981203618	
1451436121	rs267606619	MT-RNR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	1	2	tobramycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451436121	
981238341	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*4, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11	CYP2C9	1A		Tier 1 VIP	675.75	Dosage	130	215	warfarin	Cardiovascular Diseases	2021-10-05	https://www.pharmgkb.org/clinicalAnnotation/981238341	Pediatric
1451436138	rs267606618	MT-RNR1	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	2	3	kanamycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451436138	
981419257	HLA-B*57:01:01	HLA-B	1A		Tier 1 VIP	325.75	Toxicity	11	14	abacavir	Drug Hypersensitivity;HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981419257	
1447989739	rs78060119	DPYD	1A		Rare Variant; Tier 1 VIP	98.75	Toxicity	2	3	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989739	Pediatric
981419260	HLA-B*58:01	HLA-B	1A		Tier 1 VIP	181.375	Toxicity	38	41	allopurinol	Drug Hypersensitivity;drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981419260	Pediatric
1451434880	rs267606617	MT-RNR1	1A		Rare Variant; Tier 1 VIP	101.75	Toxicity	11	12	kanamycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451434880	Pediatric
1449191413	rs77834169	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191413	
1449191424	rs397508759	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191424	
1449191430	rs121908752	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191430	
1449191643	rs121908753	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191643	
1449191649	rs74551128	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191649	
1449191664	rs397508288	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191664	
1451244740	rs4149056	SLCO1B1	1A		Tier 1 VIP	102.0	Toxicity	3	5	pravastatin	statin-related myopathy	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451244740	
1451678460	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	102.0	Toxicity	3	5	pravastatin	statin-related myopathy	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451678460	
1450806874	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	214.9375	Metabolism/PK	9	16	lansoprazole	Gastroesophageal Reflux	2021-04-26	https://www.pharmgkb.org/clinicalAnnotation/1450806874	Pediatric
1451434930	rs267606617	MT-RNR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	5	7	tobramycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451434930	Pediatric
1451678112	rs4149056	SLCO1B1	1A		Tier 1 VIP	103.5	Metabolism/PK	2	3	lovastatin;lovastatin acid		2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451678112	
1451678210	rs4149056	SLCO1B1	1A		Tier 1 VIP	102.5	Metabolism/PK	2	3	pitavastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451678210	
1451678188	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	103.5	Metabolism/PK	2	3	lovastatin;lovastatin acid		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451678188	
1450814813	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37	SLCO1B1	1A		Tier 1 VIP	106.125	Metabolism/PK	5	6	pitavastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1450814813	
1449191734	rs121909020	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191734	
1451465324	rs4149056	SLCO1B1	1A		Tier 1 VIP	103.5	Toxicity	1	2	lovastatin	statin-related myopathy	2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451465324	
981420042	rs121434568	EGFR	1A		Rare Variant	190.5	Efficacy	24	45	gefitinib	Carcinoma, Non-Small-Cell Lung	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981420042	
1451434900	rs267606617	MT-RNR1	1A		Rare Variant; Tier 1 VIP	107.0	Toxicity	34	35	streptomycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451434900	Pediatric
1447681932	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*31, CYP2D6*35, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	116.4375	Metabolism/PK	12	21	metoprolol	Hypertension	2021-04-30	https://www.pharmgkb.org/clinicalAnnotation/1447681932	
981755803	rs75527207	CFTR	1A		Rare Variant; Tier 1 VIP	234.875	Efficacy	28	30	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981755803	Pediatric
1449191682	rs397508442	CFTR	1A		Rare Variant; Tier 1 VIP	200.25	Efficacy	2	4	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191682	
982030369	rs12777823		1A			109.25	Dosage	5	7	warfarin		2021-04-12	https://www.pharmgkb.org/clinicalAnnotation/982030369	
1183630065	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*9, CYP2C19*10, CYP2C19*17, CYP2C19*24, CYP2C19*26	CYP2C19	1A		Tier 1 VIP	228.8125	Metabolism/PK	28	38	omeprazole	Gastroesophageal Reflux	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183630065	Pediatric
1183620575	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36	CYP2D6	1A		Tier 1 VIP	103.5	Metabolism/PK	3	4	propafenone	Arrhythmias, Cardiac;Tachycardia	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183620575	
982014094	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35xN	CYP2D6	1A		Tier 1 VIP	102.25	Efficacy	3	5	ondansetron	Vomiting	2021-09-16	https://www.pharmgkb.org/clinicalAnnotation/982014094	
1183689217	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	268.5625	Metabolism/PK	47	77	voriconazole		2021-04-26	https://www.pharmgkb.org/clinicalAnnotation/1183689217	Pediatric
982037423	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	CYP2D6	1A		Tier 1 VIP	117.5	Metabolism/PK	12	18	venlafaxine	Depressive Disorder;Obsessive-Compulsive Disorder	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/982037423	
1451253260	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*81	CYP2D6	1A		Tier 1 VIP	103.25	Toxicity	9	11	venlafaxine	agitation;Alcohol-Related Disorders;cardiotoxicity;Depression;Depressive Disorder;Depressive Disorder, Major;Drug Toxicity;dysphoria;Edema;Nausea;Obsessive-Compulsive Disorder;Tachycardia;Vomiting	2021-05-04	https://www.pharmgkb.org/clinicalAnnotation/1451253260	
982047500	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11, CYP2C9*13, CYP2C9*14, CYP2C9*16, CYP2C9*29, CYP2C9*31, CYP2C9*33, CYP2C9*37, CYP2C9*39, CYP2C9*42, CYP2C9*43, CYP2C9*45, CYP2C9*50, CYP2C9*52, CYP2C9*55	CYP2C9	1A		Tier 1 VIP	337.125	Metabolism/PK	19	52	phenytoin	Epilepsy	2021-10-14	https://www.pharmgkb.org/clinicalAnnotation/982047500	Pediatric
1183631061	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17	CYP2D6	1A		Tier 1 VIP	107.4375	Metabolism/PK	14	20	haloperidol	Schizophrenia	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183631061	Pediatric
1183619068	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	105.875	Metabolism/PK	7	11	aripiprazole	Psychotic Disorders;schizoaffective disorder;Schizophrenia	2021-10-19	https://www.pharmgkb.org/clinicalAnnotation/1183619068	
1449191690	rs141033578	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191690	
1451439812	rs267606619	MT-RNR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	1	2	kanamycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451439812	
1451435940	rs267606619	MT-RNR1	1A		Rare Variant; Tier 1 VIP	101.0	Toxicity	5	6	streptomycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451435940	
1447953029	rs193922770	RYR1	1A		Rare Variant; Tier 1 VIP	101.0	Toxicity	7	8	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447953029	
1451436140	rs267606618	MT-RNR1	1A		Rare Variant; Tier 1 VIP	100.75	Toxicity	3	4	streptomycin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451436140	
1449191708	rs150212784	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191708	
1043859155	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	203.8125	Metabolism/PK	13	19	clomipramine	Depressive Disorder, Major;Mental Disorders	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1043859155	
1449191722	rs397508513	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191722	
1451434860	rs267606617	MT-ND1;MT-RNR1	1A		Rare Variant; Tier 1 VIP	108.0	Toxicity	28	29	gentamicin	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1451434860	Pediatric
1449191740	rs202179988	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191740	
1043859430	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	216.125	Metabolism/PK	6	16	doxepin		2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1043859430	
1183616699	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	206.0	Metabolism/PK	4	8	clomipramine	Mental Disorders	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183616699	
1449191752	rs186045772	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191752	
1449191758	rs75541969	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191758	
1449191770	rs11971167	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191770	
1447676595	HLA-B*15:02:01	HLA-B	1A		Tier 1 VIP	107.5	Toxicity	9	11	lamotrigine	Epidermal Necrolysis, Toxic;Epilepsy;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-03-01	https://www.pharmgkb.org/clinicalAnnotation/1447676595	
1449191746	rs78769542	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191746	
1449188570	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1B		Tier 1 VIP	34.0	Toxicity	15	20	acenocoumarol	over-anticoagulation	2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1449188570	
827848365	rs1801133	MTHFR	2A		Tier 1 VIP	23.25	Toxicity	32	35	methotrexate	Drug Toxicity;hematotoxicity;Leukopenia;Lymphoma;mucositis;Neoplasms;Neutropenia;Osteosarcoma;Precursor Cell Lymphoblastic Leukemia-Lymphoma;primary central nervous system lymphoma;Thrombocytopenia;Toxic liver disease	2022-02-25	https://www.pharmgkb.org/clinicalAnnotation/827848365	Pediatric
1449309937	rs121918596	RYR1	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	2	3	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449309937	Pediatric
1449269868	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	2A		Tier 1 VIP	10.5	Toxicity	11	15	acenocoumarol	Hemorrhage	2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1449269868	
1450929851	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN	CYP2D6	1A		Tier 1 VIP	103.25	Efficacy	1	2	tropisetron	Vomiting	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929851	
1451244700	rs4149056	SLCO1B1	1A		Tier 1 VIP	101.875	Metabolism/PK	2	3	fluvastatin		2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451244700	
1449747595	rs193922768	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	2	3	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449747595	
1183617103	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	212.0	Metabolism/PK	6	11	imipramine	Depressive Disorder;Depressive Disorder, Major	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183617103	
1184997207	HLA-B*59:01:01:01	HLA-B	2A		Tier 1 VIP	8.75	Toxicity	6	6	methazolamide	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184997207	
1183617651	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	213.0	Metabolism/PK	10	19	amitriptyline	Depressive Disorder;Mental Disorders	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1183617651	
1444608367	rs267606617	MT-RNR1	1A		Rare Variant; Tier 1 VIP	108.5	Toxicity	31	32	aminoglycoside antibacterials	Ototoxicity	2021-06-15	https://www.pharmgkb.org/clinicalAnnotation/1444608367	Pediatric
1183619004	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	206.625	Metabolism/PK	5	10	sertraline	Mental Disorders	2021-04-26	https://www.pharmgkb.org/clinicalAnnotation/1183619004	
1451241420	NAT2*4, NAT2*5A, NAT2*5B, NAT2*5D, NAT2*6A, NAT2*6B, NAT2*7A, NAT2*7B, NAT2*12A, NAT2*13A, NAT2*14A	NAT2	1B		Tier 1 VIP	45.75	Toxicity	33	37	Drugs For Treatment Of Tuberculosis;isoniazid	drug-induced liver injury;Hepatitis, Toxic;Toxic liver disease;Tuberculosis	2022-06-20	https://www.pharmgkb.org/clinicalAnnotation/1451241420	Pediatric
1448635217	NUDT15*1, NUDT15*2, NUDT15*3	NUDT15	1A		Tier 1 VIP	208.125	Dosage	5	9	mercaptopurine	Precursor Cell Lymphoblastic Leukemia-Lymphoma	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1448635217	Pediatric
1451703980	HLA-C*06:02:01:01, HLA-C*07:27:01, HLA-C*08:01	HLA-C	2B			10.5	Toxicity	2	4	sulfamethoxazole / trimethoprim	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2022-03-03	https://www.pharmgkb.org/clinicalAnnotation/1451703980	
1451237240	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*6	TPMT	1A		Tier 1 VIP	122.25	Toxicity	37	43	azathioprine	Leukopenia;Myelosuppression	2022-04-13	https://www.pharmgkb.org/clinicalAnnotation/1451237240	Pediatric
1451274090	rs67376798	DPYD	1A		Rare Variant; Tier 1 VIP	231.25	Toxicity	28	30	capecitabine	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451274090	
1451266120	rs67376798	DPYD	1A		Rare Variant; Tier 1 VIP	104.0	Toxicity	3	4	tegafur	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451266120	
1451288269	rs56038477	DPYD	1A		Tier 1 VIP	199.75	Toxicity	11	13	capecitabine	Neoplasms	2022-10-26	https://www.pharmgkb.org/clinicalAnnotation/1451288269	
1451704000	HLA-B*13:01:01, HLA-B*15:02:01, HLA-B*38:02:01	HLA-B	2A		Tier 1 VIP	11.5	Toxicity	2	4	sulfamethoxazole / trimethoprim	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2022-03-03	https://www.pharmgkb.org/clinicalAnnotation/1451704000	
827843617	rs3918290	DPYD	1A		Rare Variant; Tier 1 VIP	255.75	Toxicity	52	62	fluorouracil	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/827843617	Pediatric
1184986174	rs75017182	DPYD	1A		Tier 1 VIP	199.5	Toxicity	9	11	fluorouracil	Neoplasms	2022-10-27	https://www.pharmgkb.org/clinicalAnnotation/1184986174	
1449575645	rs56005131	DPYD	1A		Rare Variant; Tier 1 VIP	100.0	Other	1	2	fluorouracil		2021-05-25	https://www.pharmgkb.org/clinicalAnnotation/1449575645	
982035703	rs2884737	VKORC1	2A		Tier 1 VIP	11.25	Dosage	5	5	warfarin		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982035703	
1449575662	rs148994843	DPYD	1A		Rare Variant; Tier 1 VIP	100.0	Other	2	3	fluorouracil		2021-05-25	https://www.pharmgkb.org/clinicalAnnotation/1449575662	
1451448820	NUDT15*1, NUDT15*2, NUDT15*3	NUDT15	1A		Tier 1 VIP	208.25	Toxicity	3	5	mercaptopurine	Leukopenia;Neutropenia	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451448820	Pediatric
982029857	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	107.9375	Metabolism/PK	12	19	tamoxifen	Breast Neoplasms	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/982029857	
1451215020	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	1B		Tier 1 VIP	27.375	Toxicity	24	29	FOLFIRI;irinotecan	Diarrhea	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451215020	Pediatric
655384621	rs20455	KIF6	2B			8.5	Efficacy	4	5	pravastatin	Coronary Disease;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384621	
1451243216	CYP3A5*1, CYP3A5*3	CYP3A5	2A		Tier 1 VIP	8.0	Dosage	9	9	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451243216	Pediatric
1451241700	CYP3A5*1, CYP3A5*3	CYP3A5	2A		Tier 1 VIP	16.75	Dosage	9	10	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451241700	Pediatric
1183621000	G6PD A- 202A_376G, G6PD B (wildtype), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham	G6PD	1A		Tier 1 VIP	103.0	Toxicity	21	23	rasburicase	Hemolysis;Methemoglobinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183621000	Pediatric
1183621261	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	220.25	Metabolism/PK	21	38	paroxetine		2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1183621261	Pediatric
1183629373	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	2A		Tier 1 VIP	10.625	Metabolism/PK	10	16	rabeprazole		2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183629373	
1183629796	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	1A		Tier 1 VIP	256.75	Efficacy	22	57	lansoprazole	Gastroesophageal Reflux;Helicobacter Infections	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183629796	
1451244800	rs4149056	SLCO1B1	1A		Tier 1 VIP	116.75	Metabolism/PK	17	20	atorvastatin		2022-02-15	https://www.pharmgkb.org/clinicalAnnotation/1451244800	
1183621866	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	1A		Tier 1 VIP	107.5625	Metabolism/PK	4	7	trimipramine	Mental Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183621866	
1183621987	CYP2C19*1, CYP2C19*2	CYP2C19	1A		Tier 1 VIP	103.5625	Metabolism/PK	2	4	trimipramine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183621987	
1445400172	rs118192124	RYR1	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	6	7	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400172	Pediatric
1451244720	rs4149056	SLCO1B1	1A		Tier 1 VIP	101.25	Toxicity	2	3	fluvastatin	statin-related myopathy	2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1451244720	
1183617714	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	119.5	Metabolism/PK	9	22	amitriptyline	Depressive Disorder, Major;Mental Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183617714	
1451282740	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	241.875	Metabolism/PK	11	28	escitalopram	Depressive Disorder, Major;Mental Disorders	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1451282740	
1183620386	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	1A		Tier 1 VIP	224.75	Metabolism/PK	14	25	citalopram	Depressive Disorder;Depressive Disorder, Major	2022-03-11	https://www.pharmgkb.org/clinicalAnnotation/1183620386	
1451147720	CYP3A4*1, CYP3A4*20, CYP3A4*22	CYP3A4	1A		Tier 1 VIP	102.0	Metabolism/PK	2	3	quetiapine		2022-03-18	https://www.pharmgkb.org/clinicalAnnotation/1451147720	
1451155125	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	CYP2D6	1A		Tier 1 VIP	200.75	Toxicity	3	5	tramadol	cardiotoxicity;Respiratory Insufficiency	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1451155125	Pediatric
1451163884	UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*36, UGT1A1*37	UGT1A1	1A		Tier 1 VIP	135.25	Toxicity	17	23	atazanavir;atazanavir / ritonavir	HIV Infections;Hyperbilirubinemia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451163884	Pediatric
1184996903	HLA-B*15:02:01	HLA-B	1A		Tier 1 VIP	305.75	Toxicity	4	7	oxcarbazepine	Stevens-Johnson Syndrome	2022-02-28	https://www.pharmgkb.org/clinicalAnnotation/1184996903	Pediatric
981203719	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	1A		Tier 1 VIP	390.75	Dosage	97	107	tacrolimus	heart transplantation;hemopoietic stem cell transplant;Kidney Transplantation;liver transplantation;lung transplantation	2021-10-22	https://www.pharmgkb.org/clinicalAnnotation/981203719	Pediatric
981238501	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	243.25	Toxicity	21	33	phenytoin	Epilepsy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981238501	Pediatric
981201962	rs1801159	DPYD	1A		Tier 1 VIP	86.75	Toxicity	13	16	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981201962	
655385102	rs1042713	ADRB2	2A		Tier 1 VIP	11.75	Efficacy	7	7	salmeterol	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655385102	Pediatric
655385028	rs8050894	VKORC1	1B		Tier 1 VIP	27.0	Dosage	12	12	warfarin		2021-11-19	https://www.pharmgkb.org/clinicalAnnotation/655385028	
655385307	rs1801133	MTHFR	2A		Tier 1 VIP	12.75	Toxicity	12	12	methotrexate	Arthritis, Juvenile Rheumatoid;Arthritis, Psoriatic;Arthritis, Rheumatoid;Drug Toxicity	2022-02-25	https://www.pharmgkb.org/clinicalAnnotation/655385307	Pediatric
1447673015	rs9923231	VKORC1	2A		Tier 1 VIP	9.0	Efficacy	9	9	warfarin	time in therapeutic range	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673015	Pediatric
1451092460	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	104.0	Metabolism/PK	2	4	tenoxicam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451092460	
1183704228	rs9934438	VKORC1	2A		Tier 1 VIP	13.75	Dosage	9	9	acenocoumarol		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183704228	
1451204660	UGT1A1*1, UGT1A1*28	UGT1A1	1A		Tier 1 VIP	224.0	Toxicity	33	40	FOLFIRI;irinotecan	Neutropenia	2021-04-01	https://www.pharmgkb.org/clinicalAnnotation/1451204660	Pediatric
982033279	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1B		Tier 1 VIP	61.25	Dosage	35	57	acenocoumarol		2021-10-05	https://www.pharmgkb.org/clinicalAnnotation/982033279	
1183622099	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10	CYP2D6	1A		Tier 1 VIP	116.625	Metabolism/PK	12	18	desipramine	Depressive Disorder, Major;Mental Disorders	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183622099	
1043858794	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*10, CYP2C19*17, CYP2C19*19, CYP2C19*25, CYP2C19*26	CYP2C19	1A		Tier 1 VIP	220.875	Metabolism/PK	17	21	clopidogrel		2021-05-10	https://www.pharmgkb.org/clinicalAnnotation/1043858794	
655385012	rs9923231	VKORC1	1A		Tier 1 VIP	486.375	Dosage	86	90	warfarin		2021-11-19	https://www.pharmgkb.org/clinicalAnnotation/655385012	Pediatric
1183624499	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	1A		Tier 1 VIP	218.75	Efficacy	6	13	pantoprazole	Helicobacter Infections;Ulcer	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183624499	
1043880701	SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	SLCO1B1	1A		Tier 1 VIP	114.125	Metabolism/PK	14	20	rosuvastatin		2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/1043880701	Pediatric
1183679833	rs17376848	DPYD	1A		Tier 1 VIP	94.5	Toxicity	11	13	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183679833	
1183630664	rs55886062	DPYD	1A		Rare Variant; Tier 1 VIP	206.25	Toxicity	13	15	fluorouracil	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1183630664	
1183960766	rs121908757	CFTR	1A		Rare Variant; Tier 1 VIP	204.75	Efficacy	4	6	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960766	Pediatric
1183617979	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	2A		Tier 1 VIP	12.4375	Metabolism/PK	10	11	oxycodone	Pain	2022-01-13	https://www.pharmgkb.org/clinicalAnnotation/1183617979	
1451141882	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*17, CYP2D6*41	CYP2D6	1A		Tier 1 VIP	101.3125	Metabolism/PK	6	7	hydrocodone		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451141882	Pediatric
1451236700	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13	CYP2C9	1A		Tier 1 VIP	207.875	Metabolism/PK	7	16	celecoxib		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451236700	Pediatric
1043880520	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	107.5	Metabolism/PK	6	10	pravastatin		2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1043880520	Pediatric
981419266	HLA-B*15:02:01	HLA-B	1A		Tier 1 VIP	315.75	Toxicity	18	23	phenytoin	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-06-22	https://www.pharmgkb.org/clinicalAnnotation/981419266	Pediatric
1183689558	rs6025	F5	1A		Tier 1 VIP	107.0	Toxicity	6	7	hormonal contraceptives for systemic use	Thrombosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183689558	
1183703296	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	1A		Tier 1 VIP	107.0	Metabolism/PK	2	6	lornoxicam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183703296	
1183703784	rs115232898	DPYD	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	2	3	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183703784	
1183705759	rs118192161	RYR1	1A		Rare Variant; Tier 1 VIP	107.0	Toxicity	26	27	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705759	
1451206982	UGT1A1*1, UGT1A1*28	UGT1A1	1A		Tier 1 VIP	203.75	Dosage	10	12	irinotecan		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451206982	
1183680546	rs12979860	IFNL3;IFNL4	1A			213.25	Efficacy	5	7	boceprevir;peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183680546	
1183705764	rs121918592	RYR1	1A		Rare Variant; Tier 1 VIP	104.75	Toxicity	27	30	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705764	Pediatric
1183960775	rs121909005	CFTR	1A		Rare Variant; Tier 1 VIP	202.25	Efficacy	3	5	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960775	Pediatric
1451242500	CYP2B6*1, CYP2B6*6, CYP2B6*26	CYP2B6	1A		Tier 1 VIP	200.5	Dosage	4	6	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451242500	
1183630036	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	1A		Tier 1 VIP	264.5	Efficacy	27	57	omeprazole	Esophagitis;Gastroesophageal Reflux;Helicobacter Infections;Peptic Ulcer	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1183630036	
655384799	rs1800629	TNF	2B			14.625	Efficacy	7	7	etanercept	Arthritis, Psoriatic;Arthritis, Rheumatoid;Crohn Disease;Inflammation;Psoriasis;Spondylitis, Ankylosing	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655384799	
1183888959	rs8099917	IFNL3	2A			15.5	Efficacy	6	6	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin;telaprevir	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183888959	
1451245360	rs1051266	SLC19A1	2A		Tier 1 VIP	14.125	Efficacy	9	10	methotrexate	Arthritis, Rheumatoid	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451245360	
1183960780	rs121909013	CFTR	1A		Rare Variant; Tier 1 VIP	202.0	Efficacy	2	4	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960780	Pediatric
1451526333	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	1A		Tier 1 VIP	222.75	Toxicity	14	19	simvastatin	statin-related myopathy	2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/1451526333	
1183705773	rs118192162	RYR1	1A		Rare Variant; Tier 1 VIP	102.5	Toxicity	4	5	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705773	
1183705778	rs118192163	RYR1	1A		Rare Variant; Tier 1 VIP	101.5	Toxicity	12	13	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705778	Pediatric
1449296086	CYP3A4*1, CYP3A4*18, CYP3A4*36	CYP3A4	2A		Tier 1 VIP	8.875	Dosage	9	10	fentanyl	Pain, Postoperative	2022-03-23	https://www.pharmgkb.org/clinicalAnnotation/1449296086	
1183705698	rs118192172	RYR1	1A		Rare Variant; Tier 1 VIP	106.75	Toxicity	51	55	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705698	Pediatric
1447673005	rs9923231	VKORC1	1B		Tier 1 VIP	26.0	Toxicity	17	17	warfarin	over-anticoagulation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447673005	Pediatric
1447672998	rs9923231	VKORC1	2A		Tier 1 VIP	17.75	Efficacy	11	12	warfarin	time to therapeutic inr	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447672998	Pediatric
1449556772	rs4149056	SLCO1B1	1A		Tier 1 VIP	110.625	Metabolism/PK	9	10	simvastatin;simvastatin acid		2022-02-14	https://www.pharmgkb.org/clinicalAnnotation/1449556772	Pediatric
1183705812	rs121918593	RYR1	1A		Rare Variant; Tier 1 VIP	105.5	Toxicity	35	36	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705812	Pediatric
1183689079	CYP2D6*1, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*92, CYP2D6*96	CYP2D6	1A		Tier 1 VIP	210.8125	Metabolism/PK	9	15	atomoxetine	Attention Deficit Disorder with Hyperactivity	2021-04-29	https://www.pharmgkb.org/clinicalAnnotation/1183689079	Pediatric
1445401793	rs1801160	DPYD	1A		Tier 1 VIP	101.25	Other	6	7	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401793	
1183705783	rs118192167	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	1	2	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183705783	
1183960785	rs121909041	CFTR	1A		Rare Variant; Tier 1 VIP	202.0	Efficacy	2	4	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960785	Pediatric
827862764	rs12979860	IFNL3;IFNL4	1A			350.5	Efficacy	69	86	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/827862764	Pediatric
1451237326	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	1A		Tier 1 VIP	109.125	Dosage	9	11	azathioprine	dose reduction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451237326	Pediatric
1451809140	HLA-B*15:02:01	HLA-B	2A		Tier 1 VIP	11.25	Toxicity	4	5	antiepileptics	Epidermal Necrolysis, Toxic;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-06-23	https://www.pharmgkb.org/clinicalAnnotation/1451809140	
1183960795	rs267606723	CFTR	1A		Rare Variant; Tier 1 VIP	202.0	Efficacy	2	4	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960795	Pediatric
1183960800	rs74503330	CFTR	1A		Rare Variant; Tier 1 VIP	202.0	Efficacy	3	5	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960800	Pediatric
1451208740	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	2A		Tier 1 VIP	24.875	Metabolism/PK	14	16	SN-38		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451208740	Pediatric
1451251080	CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22	CYP3A4	2A		Tier 1 VIP	9.75	Dosage	8	8	tacrolimus	Kidney Transplantation;Organ Transplantation	2021-05-20	https://www.pharmgkb.org/clinicalAnnotation/1451251080	Pediatric
1183621997	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14	CYP2D6	1A		Tier 1 VIP	125.875	Metabolism/PK	23	32	risperidone	Psychotic Disorders;Schizophrenia	2021-04-30	https://www.pharmgkb.org/clinicalAnnotation/1183621997	Pediatric
1183960805	rs80282562	CFTR	1A		Rare Variant; Tier 1 VIP	202.0	Efficacy	2	4	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183960805	Pediatric
1184133833	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9, CYP2B6*18, CYP2B6*28	CYP2B6	1A		Tier 1 VIP	361.5	Metabolism/PK	44	69	efavirenz	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184133833	Pediatric
1184514050	rs116855232	NUDT15	1A		Tier 1 VIP	140.25	Toxicity	17	20	azathioprine	Inflammatory Bowel Diseases;Myelosuppression	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184514050	Pediatric
1184996860	HLA-B*57:01:01	HLA-B	1A		Tier 1 VIP	105.75	Toxicity	1	3	flucloxacillin	drug-induced liver injury	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184996860	
1445400924	rs63749869	RYR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	5	6	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445400924	
1445401008	rs1800559	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.5	Toxicity	3	5	desflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445401008	
1447672658	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	1A		Tier 1 VIP	139.75	Toxicity	29	34	warfarin	over-anticoagulation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447672658	Pediatric
1447672988	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	1A		Tier 1 VIP	342.375	Toxicity	33	50	warfarin	Hemorrhage	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447672988	Pediatric
1447979749	rs113993960	CFTR	1A		Rare Variant; Tier 1 VIP	123.375	Efficacy	11	16	ivacaftor / lumacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447979749	Pediatric
1447989671	rs72549303	DPYD	1A		Tier 1 VIP	100.125	Other	3	4	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989671	
1447989678	rs72549309	DPYD	1A		Rare Variant; Tier 1 VIP	100.125	Other	2	3	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989678	
1447989706	rs1801266	DPYD	1A		Rare Variant; Tier 1 VIP	100.125	Other	3	5	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989706	
1447989723	rs1801268	DPYD	1A		Rare Variant; Tier 1 VIP	100.125	Other	2	3	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447989723	
1448423861	rs77932196	CFTR	1A		Rare Variant; Tier 1 VIP	201.25	Efficacy	3	6	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1448423861	
1449154729	rs113993960	CFTR	1A		Rare Variant; Tier 1 VIP	108.75	Efficacy	3	4	ivacaftor / tezacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449154729	Pediatric
1449191379	rs368505753	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191379	
1449191385	rs115545701	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191385	
1449191401	rs397508537	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191401	
1449191407	rs113993958	CFTR	1A		Rare Variant; Tier 1 VIP	200.0	Efficacy	1	3	ivacaftor	Cystic Fibrosis	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449191407	
1449310234	rs193922764	RYR1	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	4	5	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449310234	Pediatric
1449310249	rs193922832	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	1	2	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449310249	
1449310265	rs193922843	RYR1	1A		Tier 1 VIP	100.0	Toxicity	1	2	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449310265	
1449563861	rs772226819	CACNA1S	1A		Rare Variant; Tier 1 VIP	100.25	Toxicity	2	3	desflurane	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449563861	
1449575656	rs59086055	DPYD	1A		Rare Variant; Tier 1 VIP	100.0	Other	2	3	fluorouracil		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449575656	
1449747617	rs193922762	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	1	2	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449747617	
1449747643	rs193922748	RYR1	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	2	3	desflurane;enflurane;halothane;isoflurane;methoxyflurane;sevoflurane;succinylcholine	Malignant Hyperthermia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449747643	
1450929867	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	CYP2D6	1A		Tier 1 VIP	103.5	Metabolism/PK	2	5	tropisetron		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450929867	
1451092541	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	103.5	Metabolism/PK	2	4	piroxicam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451092541	
1451092677	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13	CYP2C9	1A		Tier 1 VIP	207.5	Metabolism/PK	5	7	meloxicam		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451092677	
1451092720	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	1A		Tier 1 VIP	109.5	Metabolism/PK	5	9	ibuprofen		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451092720	
1451137080	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	1A		Tier 1 VIP	102.0625	Metabolism/PK	2	4	dexlansoprazole		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451137080	
1451154980	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17	CYP2D6	1A		Tier 1 VIP	233.25	Efficacy	13	22	tramadol	Pain;Pain, Postoperative	2022-01-11	https://www.pharmgkb.org/clinicalAnnotation/1451154980	
1451289660	rs59086055	DPYD	1A		Rare Variant; Tier 1 VIP	100.0	Toxicity	1	2	fluorouracil	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451289660	
1451329460	UGT1A1*1, UGT1A1*6	UGT1A1	1B		Tier 1 VIP	34.5	Toxicity	15	21	FOLFIRI;irinotecan	Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451329460	
1451241780	CYP3A5*1, CYP3A5*3	CYP3A5	1B		Tier 1 VIP	37.0	Metabolism/PK	24	25	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451241780	Pediatric
1451265448	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	1A		Tier 1 VIP	205.375	Toxicity	3	5	imipramine	Depressive Disorder	2021-04-23	https://www.pharmgkb.org/clinicalAnnotation/1451265448	
1184136380	rs11322783	IFNL4	1B			65.25	Efficacy	23	29	peginterferon alfa-2a;peginterferon alfa-2b;ribavirin	Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184136380	
1184999911	CYP3A5*1, CYP3A5*3	CYP3A5	1B		Tier 1 VIP	30.375	Metabolism/PK	26	30	tacrolimus	liver transplantation	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184999911	Pediatric
981202294	rs3745274	CYP2B6	2A		Tier 1 VIP	24.625	Metabolism/PK	16	17	nevirapine	HIV Infections	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981202294	Pediatric
981345382	rs4149056	SLCO1B1	2A		Tier 1 VIP	11.75	Toxicity	9	10	hmg coa reductase inhibitors	statin-related myopathy	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981345382	
982030836	rs10929302	UGT1A1	2A		Tier 1 VIP	11.75	Toxicity	7	8	irinotecan	Neutropenia	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030836	
982030222	NAT2*4, NAT2*5A, NAT2*5B, NAT2*5C, NAT2*6A, NAT2*6B, NAT2*6J, NAT2*6O, NAT2*7A, NAT2*7B, NAT2*7G, NAT2*12A, NAT2*13A, NAT2*14A	NAT2	2A		Tier 1 VIP	16.6875	Metabolism/PK	13	15	isoniazid	Tuberculosis	2022-06-15	https://www.pharmgkb.org/clinicalAnnotation/982030222	Pediatric
982047862	rs1799752	ACE	2A		Tier 1 VIP	13.5	Efficacy	7	8	captopril	Diabetes Mellitus, Type 2;Heart Failure;Pulmonary Disease, Chronic Obstructive	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982047862	
1154221922	rs2231142	ABCG2	2A		Tier 1 VIP	10.75	Efficacy	4	4	rosuvastatin	Hypercholesterolemia;Myocardial Infarction	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1154221922	
1183618159	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10	CYP2D6	2A		Tier 1 VIP	22.875	Dosage	8	14	tramadol	Pain	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183618159	
1183681792	HLA-B*13:01:01	HLA-B	2A		Tier 1 VIP	22.25	Toxicity	6	8	dapsone	Drug Hypersensitivity;drug reaction with eosinophilia and systemic symptoms;Leprosy;Maculopapular Exanthema;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183681792	
1183693378	HLA-B*40:01:01	HLA-B	2A		Tier 1 VIP	8.25	Toxicity	6	6	carbamazepine	drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2022-01-10	https://www.pharmgkb.org/clinicalAnnotation/1183693378	
1444666386	rs28399499	CYP2B6	2A		Tier 1 VIP	9.5	Toxicity	4	4	nevirapine	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666386	
1444686843	rs4646437	CYP3A4	2A		Tier 1 VIP	10.5	Metabolism/PK	6	6	tacrolimus	Kidney Transplantation;liver transplantation;Proteinuria	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444686843	Pediatric
1445421156	CYP2B6*1, CYP2B6*2, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22, CYP2B6*30	CYP2B6	2A		Tier 1 VIP	18.125	Metabolism/PK	12	16	bupropion		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1445421156	
1447672600	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13, CYP2C9*14	CYP2C9	2A		Tier 1 VIP	10.5	Efficacy	10	15	warfarin	Atrial Fibrillation;heart valve replacement	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1447672600	Pediatric
1449269910	rs9923231	VKORC1	2A		Tier 1 VIP	12.25	Toxicity	26	26	warfarin	Hemorrhage	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1449269910	Pediatric
1448104189	CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*18	CYP2B6	2A		Tier 1 VIP	13.625	Metabolism/PK	9	12	methadone	Heroin Dependence;Opioid-Related Disorders	2021-05-18	https://www.pharmgkb.org/clinicalAnnotation/1448104189	
1451243676	rs9923231	VKORC1	2A		Tier 1 VIP	8.25	Toxicity	3	4	phenprocoumon	Hemorrhage;over-anticoagulation;time above therapeutic range	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451243676	
1451244040	rs9934438	VKORC1	2A		Tier 1 VIP	9.25	Dosage	4	4	phenprocoumon		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451244040	Pediatric
1451261620	rs3788853	XPNPEP2	2B			8.25	Toxicity	3	3	Ace Inhibitors, Plain	Angioedema	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451261620	
1451266065	rs3918290	DPYD	1A		Rare Variant; Tier 1 VIP	104.0	Toxicity	3	4	tegafur	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451266065	
1451254525	rs71647871	CES1	2B		Rare Variant	6.75	Efficacy	2	3	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451254525	
981204902	rs16969968	CHRNA5	2B			11.5	Toxicity	17	19	nicotine	Tobacco Use Disorder	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/981204902	
655386657	rs25487	XRCC1	2B			11.25	Efficacy	16	19	Platinum compounds	Neoplasms	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/655386657	
982030805	rs71647871	CES1	2B		Rare Variant	4.0	Metabolism/PK	3	3	clopidogrel		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/982030805	
1183492249	rs7412	APOE	2B			12.5	Efficacy	5	5	atorvastatin	Coronary Disease;Hyperlipidemias	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1183492249	
1184654139	HLA-C*03:02	HLA-C	2B			19.5	Toxicity	5	6	allopurinol	Epidermal Necrolysis, Toxic;severe cutaneous adverse reactions;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1184654139	
1444608384	rs396991	FCGR3A	2B			8.0	Efficacy	3	3	rituximab	Arthritis, Rheumatoid;Neuromyelitis Optica	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444608384	
1444666130	HLA-DPB1*03:01:01	HLA-DPB1	2B			11.0	Toxicity	3	3	aspirin	Asthma	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444666130	
1444699749	HLA-DRB1*01:01:01	HLA-DRB1	2B			11.5	Toxicity	6	7	nevirapine		2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444699749	
1444706709	HLA-C*01:02:01	HLA-C	2B			8.0	Toxicity	3	3	methazolamide	Epidermal Necrolysis, Toxic;Stevens-Johnson Syndrome	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1444706709	
1446905691	rs1127354	ITPA	2B			24.0	Toxicity	14	14	peginterferon alfa-2b;ribavirin	Anemia;Hepatitis C, Chronic	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1446905691	
1450810451	rs671	ALDH2	2B		Rare Variant	4.75	Toxicity	2	2	ethanol	Alcoholism	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1450810451	
1451250540	rs121434569	EGFR	2B		Rare Variant	8.75	Efficacy	16	16	gefitinib	Carcinoma, Non-Small-Cell Lung;Drug Resistance	2021-03-24	https://www.pharmgkb.org/clinicalAnnotation/1451250540	
1043880630	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37	SLCO1B1	1A		Tier 1 VIP	105.5	Metabolism/PK	9	10	atorvastatin		2022-02-10	https://www.pharmgkb.org/clinicalAnnotation/1043880630	
1183617478	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	1A		Tier 1 VIP	101.6875	Metabolism/PK	2	3	zuclopenthixol	Schizophrenia	2021-05-04	https://www.pharmgkb.org/clinicalAnnotation/1183617478	
1183703748	rs61742245	VKORC1	2A		Rare Variant; Tier 1 VIP	7.25	Dosage	6	6	warfarin		2021-11-18	https://www.pharmgkb.org/clinicalAnnotation/1183703748	
1450415170	CYP2D6*1, CYP2D6*4	CYP2D6	1A		Tier 1 VIP	103.0	Dosage	2	3	metoprolol	Heart Failure	2021-05-03	https://www.pharmgkb.org/clinicalAnnotation/1450415170	
1451266020	rs55886062	DPYD	1A		Rare Variant; Tier 1 VIP	102.25	Toxicity	2	3	tegafur	Neoplasms	2021-05-24	https://www.pharmgkb.org/clinicalAnnotation/1451266020	
1451289700	rs75017182	DPYD	1A		Tier 1 VIP	200.0	Other	4	6	fluorouracil		2022-10-27	https://www.pharmgkb.org/clinicalAnnotation/1451289700	
1183701224	HLA-A*31:01:02	HLA-A	1A			242.875	Toxicity	16	29	carbamazepine	Drug Hypersensitivity;drug reaction with eosinophilia and systemic symptoms;Epidermal Necrolysis, Toxic;Maculopapular Exanthema;Stevens-Johnson Syndrome	2022-03-01	https://www.pharmgkb.org/clinicalAnnotation/1183701224	Pediatric
